“…Besides, a single compound can show more than one conformation, so, based on the available threedimensional structures, a strategy of constraining the conformation of flexible molecules (eg, forming a macrocycle between two solvent-exposed substituent positions of a given binder) is well-established to improve potency, selectivity, and PKs or absorption, distribution, metabolism, and excretion (ADME)-related properties (eg, metabolic stability), while having a minimal effect on the therapeutically relevant binding interaction. 69,80,81 Indeed, this approach has yielded new inhibitors with improved PK properties as well as increased enzyme affinity, as exemplified by a wide range of macrocyclic antiviral agents, such as hepatitis C virus (HCV) NS5B Figure 18). 93,94 For example, taking peptidomimetic HIV-1 gp120 antagonist 121 as a lead compound, cyclic peptide triazole (cPT) derivatives were obtained via cyclization of two solvent-exposed substituent positions, thereby locking the molecule in an active conformation.…”